Collaborators
Trusted partners advancing the science
Our research advances through strategic partnerships with leading scientists and clinicians. Together, we convert DNA‑repair and immune biology into precision‑medicine strategies, including adaptive radiation protocols and biomarker-driven clinical trials
Tim Chan, MD, PhD
Chair, Center for Immunotherapy & Precision Immuno-Oncology
Cleveland Clinic · Lerner Research Institute
We team up to connect tumor genomics and DNA repair defects to anti-tumor immunity in HRD and head and neck cancers—both in models and human material.
Nancy Y. Lee, MD, FASTRO
Vice Chair, Experimental Therapeutics; Service Chief, Head & Neck Radiation Oncology
Memorial Sloan Kettering Cancer Center
We collaborate on head and neck cancer and precision radiotherapy clinical trials. Together, we pioneered the 30 ROC trial—using hypoxia-directed imaging and whole-genome sequencing to guide dramatic radiation de-escalation to 30 Gy in HPV-associated oropharyngeal cancer.
C. Jillian Tsai, MD, PhD, MS
Associate Professor, Clinical Trialist
Princess Margaret Cancer Centre (UHN), University of Toronto
We work together on translational correlative on SBRT for oligioprogressive disease to understand when cancer is locally progressing vs. systemically progressing.
Jeremy Setton, MD
Assistant Attending Physician, Department of Radiation Oncology
Memorial Sloan Kettering Cancer Center
We collaborate on understanding mutational signatures in cancer and precision radiotherapy.
Wungki Park, MD, MS
Assistant Attending Physician, Gastrointestinal Medical Oncology
Memorial Sloan Kettering Cancer Center
With Wungki, we work to understand how HRD influences immunity in pancreatic cancer and to design biomarker-driven combination studies.
Simon N. Powell, MD, PhD
Chair, Department of Radiation Oncology
Memorial Sloan Kettering Cancer Center
We team up with the Powell lab to elucidate the mechanistic basis of mutational signatures and identify new strategies for synthetic cytotoxicity in radiotherapy trials.
Atif J. Khan, MD
Attending Radiation Oncologist
Memorial Sloan Kettering Cancer Center
We partner to understand how HRD influences immunity in breast cancer and to translate those insights into clinical protocols.
Britta Weigelt, PhD
Attending Pathologist
Memorial Sloan Kettering Cancer Center
Together we dissect gynecologic cancers with homologous recombination deficiency and other HPV-related tumors, coupling genomic profiling with translational studies.